Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 11:10 PM
Study NCT ID:
NCT00262067
Status:
UNKNOWN
Last Update Posted:
2013-12-13
First Post:
2005-12-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12
Completion Date Type:
ESTIMATED
First Submit Date:
2005-12-02
First Submit QC Date:
None
Study First Post Date:
2005-12-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-20
Results First Submit QC Date:
None
Results First Post Date:
2013-10-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-09-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-11-18
Last Update Post Date:
2013-12-13
Last Update Post Date Type:
ESTIMATED